Optimizing UHPLC-to-HPLC Method Translation for the USP Assay Method for Salicylamide

Significance of the topic

Translating modern UHPLC gradient methods to conventional HPLC platforms is a common requirement in regulated laboratories that develop methods on high-pressure instruments but perform routine analysis on lower-pressure systems. Differences in dwell volume and extra-column dispersion between instruments can shift retention times, degrade resolution and cause system suitability failure. Practical strategies that compensate for dwell-volume differences or that scale methods according to compendial guidance enable reliable method transfer while preserving assay performance and regulatory compliance.

Objectives and overview of the study

This application note demonstrates two complementary strategies to migrate a USP UHPLC gradient assay for salicylamide onto an Alliance iS HPLC System (12,000 psi): 1) adjusting gradient timing using a Gradient Start feature to compensate for instrument dwell volume, and 2) scaling the UHPLC method to a conventional HPLC column following USP General Chapter <621> guidance. The study assesses chromatographic performance, system suitability metrics (area %RSD and USP resolution between salicylic acid related compound B and salicylamide), and practical trade-offs for each approach.

Methodology

• Sample preparation: Standard and system suitability solutions of USP Salicylamide RS and USP Salicylic Acid Related Compound B RS prepared in 50:50 acetonitrile/water (standard 0.2 mg/mL; system suitability 1.0 mg/mL salicylamide and 1 µg/mL RCB).
• Initial UHPLC method parameters (executed on the Alliance iS HPLC with UHPLC column): 2.1 × 100 mm, 1.8 µm ACQUITY Premier HSS T3; flow 0.30 mL/min; column temp 35 °C; injection 1 µL; UV detection at 300 nm; mobile phases A = 0.1% formic acid in water, B = acetonitrile.
• Scaled HPLC method parameters: 4.6 × 150 mm, 3.5 µm XBridge BEH C18 column; flow 0.74 mL/min; injection 7 µL; column temp 35 °C; same mobile phases and detection as above. Scaled gradient, run time and volumes were calculated to preserve L/dp ratio within 25% per USP <621>.
• Data handling and tools: Empower 3 FR5/3.7 CDS for acquisition and diagnostics; Waters Column Calculator used for method scaling; Gradient Start instrument feature used to offset dwell-volume effects.

Used instrumentation

• Alliance iS HPLC System (12,000 psi capable)
• ACQUITY Premier HSS T3 Column, 2.1 × 100 mm, 1.8 µm (for UHPLC-format runs)
• XBridge BEH C18 Column, 4.6 × 150 mm, 3.5 µm (for scaled HPLC runs)
• UV detector set at 300 nm; sample vials and temperatures as described in the procedure
• Empower 3 chromatography data system and Waters Column Calculator software

Main results and discussion

• Direct migration of the compendial UHPLC gradient to the HPLC system produced poor chromatography and indeterminate USP resolution because the system’s larger dwell volume created an effective unprogrammed isocratic hold and prevented return to initial conditions during injection. System pressure traces showed the pressure remained depressed until the end of injection, indicating incomplete delivery of initial conditions to the column.
• Strategy 1 — Gradient Start adjustment: By evaluating pressure traces and calculating required equilibration volume (~1.2 mL for the column), the authors empirically advanced the gradient by 1157 µL (3.86 min). This restored initial pressure prior to the end of injection and separated salicylic acid RCB and salicylamide as distinct peaks. Measured USP resolution (Rs) between RCB and salicylamide improved to 3.6 and the area %RSD for salicylamide in the standard solution was 0.26% (acceptance ≤ 0.73%). This approach corrected the gradient delay without changing the column, flow rate or injection volume.
• Strategy 2 — Method scaling to HPLC column: The method was scaled from a 2.1 × 100 mm, 1.8 µm column to a 4.6 × 150 mm, 3.5 µm column using the Waters Column Calculator (preserving L/dp within 25% per USP <621>). Resulting parameters included flow 0.74 mL/min and injection 7 µL. The scaled method delivered higher resolution (Rs = 8.2) and lower area %RSD (0.13%) but required longer run time, greater solvent consumption and larger sample volumes. The larger column volume also reduced sensitivity of peaks to extra-column band broadening, contributing to improved resolution.
• Comparison: Both strategies met USP system suitability criteria for the salicylamide assay. Gradient Start provides a rapid, low-resource fix for dwell-volume mismatch but does not address increased extra-column dispersion effects. Scaling to a larger HPLC column more fully compensates for extra-column band broadening at the expense of throughput and solvent/sample usage.

Benefits and practical applications

• Gradient Start allows laboratories to translate UHPLC gradient methods to HPLC platforms without changing stationary phase or performing complex re-calculations, enabling faster method deployment on diverse instrument fleets.
• Method scaling following USP <621> and assisted by software calculators provides a robust solution when extra-column dispersion compromises critical resolution; it is suited to routine QC environments where throughput trade-offs are acceptable in exchange for improved reproducibility.
• Using an HPLC system with an extended pressure range (12,000 psi) expands flexibility: labs can run both UHPLC and conventional HPLC separations on the same platform, simplifying instrument inventories.

Future trends and potential uses

• Broader adoption of integrated instrument diagnostics (pressure traces, dwell-volume measurement) and software-assisted scaling will streamline method transfers across multi-instrument laboratories and CROs.
• Automated method translation tools (calculators embedded in CDS) are likely to evolve to include optimization of extra-column dispersion and solvent consumption trade-offs, enabling more automated decision-making during transfer.
• As regulated methods increasingly originate on UHPLC platforms, hybrid solutions — instrument features that compensate for dwell volume plus strategic column selection — will become standard practice for robust routine testing.

Conclusion

The application note demonstrates two viable approaches to translate a USP UHPLC salicylamide assay onto an HPLC platform: adjusting gradient timing with a Gradient Start to compensate for dwell volume, and method scaling to a larger HPLC column based on USP <621>. Both approaches achieved system suitability: Gradient Start provided a quick fix with minimal resource impact (Rs = 3.6; area %RSD = 0.26%), while method scaling produced greater resolution and precision (Rs = 8.2; area %RSD = 0.13%) at the expense of throughput and solvent/sample use. The combination of higher-pressure HPLC hardware and integrated software tools facilitates flexible, regulatory-compliant method migration across instrument types.

References

1. Dong M. More Myths in Ultrahigh-Pressure Liquid Chromatography. LCGC Europe. 2013 Nov;26(11).
2. Dong M. UHPLC, Part I: Perspectives and Instrumental Features. LCGC North America. 2017 Jun;35(6):374-81.
3. United States Pharmacopeia. Chromatography <621>. USP–NF. Rockville, MD: USP; 01 Dec 2024.
4. United States Pharmacopeia. Salicylamide Monograph. USP–NF. Rockville, MD: USP; 13 Aug 2025.
5. Hong P, McConville P. Dwell Volume and Extra-Column Volume: What Are They and How Do They Impact Method Transfer? Waters White Paper. 2018 Apr.
6. Dolan J. Gradient Elution, Part IV: Dwell-Volume Problems. LCGC North America. 2013 Jun;31(6).
7. Dolan J. Dwell Volume Revisited. LCGC North America. 2006 May;24(5).
8. Berthelette K, Turner J, Kalwood J, Haynes K. Faster, Simpler Method Scaling Across Particle Sizes Using the Waters Columns Calculator Compared to Manual Calculation Workflow. Waters Application Note. 2023 Jul.